HKUST-led int'l research achieves breakthrough in Alzheimer's diagnosis, management

STORY: HKUST-led int'l research achieves breakthrough in Alzheimer's diagnosis, management SHOOTING TIME: Feb. 19, 2024 DATELINE: Feb. 21, 2024 LENGTH: 00:01:21 LOCATION: HONG KONG, China CATEGORY: HEALTH SHOTLIST: 1. various of the press conference STORYLINE: The international research collaboration led by the Hong Kong University of Science and Technology (HKUST) has reached a significant milestone in the diagnosis and management of Alzheimer's disease (AD), according to a press conference on Monday in Hong Kong. Spearheaded by Prof. Nancy Ip, President and the Morningside Professor of Life Science at HKUST, and Director of the Hong Kong Center for Neurodegenerative Diseases (HKCeND), the team has developed an innovative blood test for the early detection of AD and mild cognitive impairment (MCI), boasting accuracy rates of over 96 percent and 87 percent, respectively. Alzheimer's disease affects over 50 million people worldwide, characterized by the accumulation of toxic amyloid beta in the brain, lea

MCI WorldCom, Sprint to merge

MCI WorldCom, Sprint to merge

NEW YORK, United States - Bernard J. Ebbers (R), president and CEO of MCI WorldCom, and William T. Esrey, chairman and CEO of Sprint Corp., speak at a news conference in New York on Oct. 5 following the announcement of a merger agreement between the second and third biggest U.S. long-distance carriers.

MCI WorldCom, Sprint to merge

MCI WorldCom, Sprint to merge

NEW YORK, United States - Bernard J. Ebbers (R), president and CEO of MCI WorldCom, and William T. Esrey, chairman and CEO of Sprint Corp., speak at a news conference in New York on Oct. 5 following the announcement of a merger agreement between the second and third biggest U.S. long-distance carriers.